HJoachimDeegMD

PubMed

• R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts.
  Liu, Z., Sinha, S., Bannister, M., Song, A., Arriaga-Gomez, E., McKeeken, A., Bonner, E., Hanson, B., Sarchi, M., Takashima, K., Zong, D., Corral, V., Nguyen, E., Yoo,...> ;Cancer Research. 2024 Feb 15
• How I reduce and treat posttransplant relapse of MDS.
  Alain Mina, Peter L Greenberg, H Joachim Deeg> ;Blood. 2024 Apr 4
• 3 citations
  Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised...
  Garcia-Manero, G., McCloskey, J., Griffiths, E., Yee, K., Zeidan, A., Al-Kali, A., Deeg, H., Patel, P., Sabloff, M., Keating, M., Zhu, N., Gabrail, N., Fazal, S., Maly...> ;The Lancet. Haematology. 2024 Jan 1
• JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.
  Rafati, M., Brown, D., Zhou, W., Jones, K., Luo, W., St Martin, A., Wang, Y., He, M., Spellman, S., Wang, T., Deeg, H., Gupta, V., Lee, S., Bolon, Y., Chanock, S., Mac...> ;Blood Advances. 2023 Dec 26
• Discovery of U2AF1 neoantigens in myeloid neoplasms.
  Lok, J., Black, R., Foster, K., Cummings, C., Woodward, K., Monahan, T., Rongvaux, A., Biernacki, M., Oehler, V., Stirewalt, D., Wu, D., Deeg, H., Bleakley, M.> ;Journal for Immunotherapy of Cancer. 2023 Dec 12
• Reward from half a match.
  H Joachim Deeg> ;Blood. 2023 Jun 22
• 3 citations
  Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study.
  Gregory A Abel, Donnie Hebert, Cecilia Lee, Dana Rollison, Nancy Gillis, Rami Komrokji, James M Foran, Jane Jijun Liu, Tareq Al Baghdadi, Joachim Deeg, Steven Gore, Wa...> ;Blood Advances. 2023 Jul 25
• 1 citations
  Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study.
  Tao Zhang, Paul Auer, Jing Dong, Corey Cutler, Amy E Dezern, Shahinaz M Gadalla, H Joachim Deeg, Aziz Nazha, Karen-Sue Carlson, Stephen Spellman, Yung-Tsi Bolon, Wael ...> ;Journal of Hematology & Oncology. 2023 Apr 11
• 3 citations
  Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions.
  Amy E DeZern, Johannes B Goll, R Coleman Lindsley, Rafael Bejar, Steffanie H Wilson, Donnie Hebert, Joachim Deeg, Ling Zhang, Steven Gore, Tareq Al Baghdadi, Jaroslaw ...> ;Blood Advances. 2023 Jul 25
• Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation.
  Jing Dong, Christopher Staffi Buradagunta, Tao Zhang, Stephen Spellman, Yung-Tsi Bolon, Amy E DeZern, Shahinaz M Gadalla, H Joachim Deeg, Aziz Nazha, Corey Cutler, Cha...> ;Journal of Hematology & Oncology. 2023 Mar 10
• 2 citations
  Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Le...
  Corentin Orvain, Eduardo Rodríguez-Arbolí, Megan Othus, Brenda M Sandmaier, H Joachim Deeg, Frederick R Appelbaum, Roland B Walter> ;Cancers. 2023 Jan 5
• 2 citations
  Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in fi...
  Roland B Walter, Brenda M Sandmaier, Megan Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Masumi U Oshima, Gary Schoch, Chris Davis, H Joachim Deeg, Rainer Storb> ;Bone Marrow Transplantation. 2023 Apr 1
• 6 citations
  Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of th...
  Nicola Polverelli, Juan Carlos Hernández-Boluda, Tomasz Czerw, Tiziano Barbui, Mariella D'Adda, Hans Joachim Deeg, Markus Ditschkowski, Claire Harrison, Nicolaus Marti...> ;The Lancet. Haematology. 2023 Jan 1
• 9 citations
  Prediction of Busulfan Clearance by Predose Plasma Metabolomic Profiling.
  Jeannine S McCune, Sandi L Navarro, K Scott Baker, Linda J Risler, Brian R Phillips, Timothy W Randolph, Laura Shireman, H Gary Schoch, H Joachim Deeg, Yuzheng Zhang, ...> ;Clinical Pharmacology and Therapeutics. 2023 Feb 1
• Correction to: Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review.
  Shernan G Holtan, Jingbo Yu, Hannah K Choe, Dilan Paranagama, Jackson Tang, Ahmad Naim, John Galvin, H Joachim Deeg> ;Bone Marrow Transplantation. 2023 Feb 1
• 1 citations
  Transplantation for myeloid neoplasms with antecedent solid tumor.
  Andrew Jay Portuguese, Aya Albittar, Ted H Gooley, Hans Joachim Deeg> ;Cancer. 2023 Jan 1
• 5 citations
  Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoi...
  Eduardo Rodríguez-Arbolí, Megan Othus, Corentin Orvain, Lucas C Zarling, Brenda M Sandmaier, Filippo Milano, Gary Schoch, Chris Davis, H Joachim Deeg, Frederick R Appe...> ;Haematologica. 2023 Jan 1
• 4 citations
  Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis.
  Derek W Brown, Weiyin Zhou, Youjin Wang, Kristine Jones, Wen Luo, Casey Dagnall, Kedest Teshome, Alyssa Klein, Tongwu Zhang, Shu-Hong Lin, Olivia W Lee, Sairah Khan, J...> ;Nature Communications. 2022 Sep 8
• 10 citations
  Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review.
  Shernan G Holtan, Jingbo Yu, Hannah K Choe, Dilan Paranagama, Jackson Tang, Ahmad Naim, John Galvin, H Joachim Deeg> ;Bone Marrow Transplantation. 2022 Oct 1
• 15 citations
  Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase ...
  Amy E DeZern, Mary Eapen, Juan Wu, Julie-An Talano, Melhem Solh, Blachy J Dávila Saldaña, Chatchada Karanes, Mitchell E Horwitz, Kanwaldeep Mallhi, Sally Arai, Nosha F...> ;The Lancet. Haematology. 2022 Sep 1
• 51 citations
  Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes.
  Asmita Mishra, Roni Tamari, Amy E DeZern, Michael T Byrne, Mahasweta Gooptu, Yi-Bin Chen, H Joachim Deeg, David Sallman, Phillip Gallacher, Anders Wennborg, Denice K H...> ;Journal of Clinical Oncology. 2022 Dec 1
• 2 citations
  Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective st...
  Shernan G Holtan, Jingbo Yu, Dilan Paranagama, Jackson Tang, Hannah K Choe, Ahmad Naim, H Joachim Deeg, John Galvin> ;Bone Marrow Transplantation. 2022 Sep 1
• 2 citations
  Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
  Lucas C Zarling, Megan Othus, Brenda M Sandmaier, Filippo Milano, Gary Schoch, Chris Davis, Marie Bleakley, H Joachim Deeg, Frederick R Appelbaum, Rainer Storb, Roland...> ;Leukemia. 2022 Jun 1
• 33 citations
  Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.
  Gabrielle Paras, Linde M Morsink, Megan Othus, Filippo Milano, Brenda M Sandmaier, Lucas C Zarling, Raffaele Palmieri, Gary Schoch, Chris Davis, Marie Bleakley, Mary E...> ;Blood. 2022 Mar 17
• 44 citations
  NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
  Peter L Greenberg, Richard M Stone, Aref Al-Kali, John M Bennett, Uma Borate, Andrew M Brunner, Wanxing Chai-Ho, Peter Curtin, Carlos M de Castro, H Joachim Deeg, Amy ...> ;Journal of the National Comprehensive Cancer Network. 2022 Feb 1
• Join now to see all

Journal Articles

• Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?  
  Vaughn,J.E., Anwer,F., Deeg,H.J., Vox Sang., 1/1/2016
• Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission  
  Walter,R.B., Sandmaier,B.M., Storer,B.E., Godwin,C.D., Buckley,S.A., Pagel,J.M., Sorror,M.L., Deeg,H.J., Storb,R., Appelbaum,F.R., Biol Blood Marrow Transplant, 1/1/2015
• Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation  
  Au,B.K., Gooley,T.A., Armand,P., Fang,M., Madtes,D.K., Sorror,M.L., Boeckh,M.J., Gibson,C.J., Deeg,H.J., Storb,R., Appelbaum,F.R., Chien,J.W., Martin,P.J., Biol Blood Marrow Transplant, 1/1/2015
• Treatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients  
  Deeg,H.J., Bone Marrow Transplant, 1/1/2015
• Impact of allogeneic stem cell trans-plantation on survival of patients less than 65 years of age with primary myelofibrosis  
  Kroger,N., Giorgino,T., Scott,B.L., Ditschkowski,M., Alchalby,H., Cervantes,F., Vannucchi,A., Cazzola,M., Morra,E., Zabelina,T., Maffioli,M., Pereira,A., Beelen,D., De..., Blood, 1/1/2015
• Therapy for hematologic cancers in older patients, quality of life, and health economics: difficult decisions  
  Deeg,H.J., Steuten,L.M., JAMA Oncology, 1/1/2015
• Relapse after allogeneic hematopoietic cell transplantation for myelodysplastic syndromes: analysis of late relapse using comparative karyotype and chromosome genome a...  
  Yeung,C.C., Gerds,A.T., Fang,M., Scott,B.L., Flowers,M.E., Gooley,T., Deeg,H.J., Biol Blood Marrow Transplant, 1/1/2015
• Quantitative analysis of glycans, related genes, and proteins in two human bone marrow stromal cell lines using an integrated strategy  
  Li,X., Li,D., Pang,X., Yang,G., Deeg,H.J., Guan,F, Exp. Hematol, 1/1/2015
• Hematopoietic cell transplantation for myelodysplastic syndrome  
  Deeg,H.J., American Society of Clinical Oncology Educational Book, 1/1/2015
• SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition  
  Kim,E., Ilagan,J.O., Liang,Y., Daubner,G.M., Lee,S.C., Ramakrishnan,A., Li,Y., Chung,Y.R., Micol,J.B., Murphy,M.E., Cho,H., Kim,M.K., Zebari,A.S., Aumann,S., Park,C.Y...., Cancer Cell, 1/1/2015
• Severe refractory immune thrombocytopenia successfully treated with high-dose pulse cyclophosphamide and eltrombopag  
  Anwer,F., Yun,S., Nair A., Ahmad,Y., Krishnadashan,R., Deeg,H.J., Case Reports in Hematology, 1/1/2015
• In support of a patient-driven initiative and petition to lower the high price of cancer drugs (Commentary)  
  Tefferi,A., Kantarjian,H., Rajkumar,S.V., Baker,L.H., Abkowitz,J.L., Adamson,J.W., Advani,R.H., Allison,J., Antman,K.H., Bast,R.C., Jr., Bennett,J.M., Benz,E.J., Jr., ..., Mayo Clin. Proc, 1/1/2015
• A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis  
  Rae,D.T., Hocum,J.D., Bii,V., Deeg,H.J., Trobridge,G.D., Oncotarget, 1/1/2015
• Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study  
  Anderlini,P., Wu,J., Gersten,I., Ewell,M., Tolar,J., Antin,J.H., Adams,R., Arai,S., Eames,G., Horwitz,M.E., McCarty,J., Nakamura,R., Pulsipher,M.A., Rowley,S., Leifer,..., The Lancet Haematology, 1/1/2015
• Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN International Working Group  
  Kroger,N.M., Deeg,H.J., Olavarria,E., Niederwieser,D., Bacigalupo,A., Barbui,T., Rambaldi,A., Mesa,R., Tefferi,A., Griesshammer,M., Gupta,V., Harrison,C., Alchalby,H.,..., Leukemia, 1/1/2015
• Hematopoietic cell transplantation as curative therapy for patients with myelofibrosis: long-term success in all age groups  
  Deeg,H.J., Bredeson,C., Farnia,S., Ballen,K., Gupta,V., Mesa,R.A., Popat,U., Hari,P., Saber,W., Seftel,M., Tamari,R., Petersdorf,E, Biol Blood Marrow Transplant, 1/1/2015
• Treosulfan and radiation-induced cytotoxicity in myeloid cell lines and primary MDS cells  
  Zang,D.Y., Holman,Z., Marcondes,A.M., Deeg,H.J., Jacobs Journal of Hematology, 1/1/2015
• Second allogeneic hematopoietic cell transplantation for patients with Fanconi anemia and bone marrow failure  
  Ayas,M., Eapen,M., Le-Rademacher,J., Carreras,J., Abdel-Azim,H., Alter,B.P., Anderlini,P., Battiwalla,M., Bierings,M., Buchbinder,D.K., Bonfim,C., Camitta,B.M., Fasth,..., Biol Blood Marrow Transplant, 1/1/2015
• Murine xenogeneic models of myelodysplastic syndrome (MDS): an essential role for stroma cells  
  Li,X., Deeg,H.J, Exp. Hematol, 1/1/2014
• Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia  
  Eckrich,M.J., Ahn,K.W., Champlin,R.E., Coccia,P., Godder,K., Horan,J., Margolis,D., Deeg,H.J., Eapen,M, Am. J. Hematol, 1/1/2014
• Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute ...  
  Gyurkocza,B., Gutman,J., Nemecek,E.R., Bar,M., Milano,F., Ramakrishnan,A., Scott,B., Fang,M., Wood,B., Pagel,J.M., Baumgart,J., Delaney,C., Maziarz,R.T., Sandmaier,B.M..., Biol Blood Marrow Transplant, 1/1/2014
• Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation  
  Castilla-Llorente,C., Martin,P.J., McDonald,G.B., Storer,B.E., Appelbaum,F.R., Deeg,H.J., Mielcarek,M., Shulman,H., Storb,R., Nash,R.A., Bone Marrow Transplant, 1/1/2014
• Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statisti...  
  Lionberger,J.M., Pagel,J.M., Sandhu,V.K., Xie,H., Shadman,M., Mawad,R., Boehm,A., Dean,C., Shannon-Dorcy,K., Scott,B.L., Deeg,H.J., Becker,P.S., Hendrie,P.C., Walter,R..., Br. J. Haematol, 1/1/2014
• Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis  
  Gupta,V., Gotlib,J., Radich,J.P., Kroger,N.M., Rondelli,D., Verstovsek,S., Deeg,H.J., Biol Blood Marrow Transplant, 1/1/2014
• Acute phase protein, a1-antitrypsin--a novel regulator of angiopoietin-like protein 4 transcription and secretion  
  Frenzel,E., Wrenger,S., Immenschuh,S., Koczulla,R., Mahadeva,R., Deeg,H.J., Dinarello,C.A., Welte,T., Marcondes,A.M., Janciauskiene,S., J. Immunol, 1/1/2014
• Join now to see all

Books/Book Chapters

• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndromes and myeloproliferative neoplasms 
  Page 613 - 624Deeg,H.J.Editors: Forman,S.J., Negrin,R.S., Antin,J.H., and Appelbaum,F.R..Wiley-BlackwellEdition 5th,2016
• Novel Insights into Myelofibrosis Pathophysiology and Treatment 
  Chapter: When and how to transplant patients with myelofibrosis 
  Deeg,H.J., Sala-Torra,O., Scott,B.L.Editors: Verstovsek,S..Future Science Group, London2015
• Hamatopoietische Stammzellen 
  Chapter: Transplantatversagen, krankheitsrezidiv, zweittransplantation 
  Page 196 - 199Platzbecker,U., Deeg,H.J.Editors: Herr,W., Theobald,M., Ehninger,G., Einsele,H., and Meyer,R.G.Deutscher arzte-Verlag GmbH, Koln2015
• Hamatopoietische Stammzellen 
  Chapter: Sekundarmalignome 
  Page 200 - 206Wagner,E.M., Deeg,H.J.Editors: Herr,W., Theobald,M., Ehninger,G., Einsele,H., and Meyer,R.G..Deutscher arzte-Verlag GmbH, Koln2015
• Neoplastic Diseases of the Blood 
  Chapter: Alternative sources of hematopoietic stem cells and their clinical applications 
  Page 1289 - 1306Gutman,J., Heimfeld,S., Deeg,H.J.Editors: Wiernik,P., Goldman,J., Dutcher,J., and Kyle,R.Cambridge University Press, Cambridge, UKEdition Fift,2013
• Myelodysplastic Syndromes 
  Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Myelodysplastic Syndromes 
  Chapter: MDS stem cell biology 
  Page 73 - 84Greenblatt,S.M., Deeg,H.J., Nimer,S.D.Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Hematopoietic cell transplantation (HCT). 
  Chapter: Hematopoietic cell transplantation (HCT). 
  Page 211 - 228Deeg,H.JEditors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Clinical Decision Support: Hematology 
  Chapter: Hematopoeitic cell transplantation for non-malignant diseases 
  Deeg,H.J.Editors: Benz,E.J., Berliner,N., Brodsky,R.A., LaCasce,A.S., and Moake,J.L..Decision Support in Medicine, LLC, Wilmington, DE2012
• Myeloproliferative Neoplasms: Biology and Therapy 
  Chapter: Hematopoietic cell transplantation for myelofibrosis 
  Page 139 - 150Kerbauy,D.M.B., Deeg,H.J.Editors: Verstovsek,S. and Tefferi,A..Humana Press, New York, NY2011
• Transplant Infections 
  Chapter: Introduction to hematopoietic stem cell transplantation 
  Page 1 - 12Rezvani,A.R., Deeg,H.J.Editors: Bowden,R., Ljungman,P., and Snydman,D.R..Lippincott Williams & Wilkins, Philadelphia, PAEdition Thir,2010
• Hematopoietic Stem Cell Transplantation in Clinical Practice 
  Chapter: Acute graft-versus-host disease 
  Page 387 - 400Deeg,H.J., Flowers,M.E.D.Editors: Treleaven,J. and Barrett,A.J..Elsevier Ltd, Edinburgh, UK2009
• Hematopoietic Stem Cell Transplantation in Clinical Practice 
  Chapter: Chronic graft-versus-host disease 
  Page 401 - 407Flowers,M.E.D., Deeg,H.JEditors: Treleaven,J. and Barrett,A.J..Elsevier Ltd, Edinburgh, UK2009
• Hematology Basic Principles and Practice 
  Chapter: Hematopoietic cell transplantation for acquired nonmalignant diseases and myelodysplastic syndrome 
  Page 1561 - 1576Scott,B.L., Deeg,H.J.Editors: Hoffman,R., Benz,E.J., Jr., Shattil,S.J., Furie,B., Silberstein,L.E., McGlave,P., and Heslop,H..Churchill Livingstone Elsevier, Philadelphia, PAEdition 5th,2009
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndrome and myeloproliferative disorders 
  Page 827 - 844Deeg,H.J.Editors: Appelbaum,F.R., Forman,S.J., Negrin,R.S., and Blume,K.G..Wiley-Blackwell, Oxford, UKEdition Four,2009
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Delayed nonmalignant complications after hematopoietic cell transplantation 
  Page 1620 - 1637Flowers,M.E.D., Deeg,H.J.Editors: Appelbaum,F.R., Forman,S.J., Negrin,R.S., and Blume,K.G..Wiley-Blackwell, Oxford, UKEdition Four,2009
• Chronic Graft Versus Host Disease: Interdisciplinary Management 
  Chapter: Secondary malignancies and other late effects 
  Page 326 - 334Socie,G., Deeg,H.J.Editors: Vogelsang,G.B. and Pavletic,S.Z..Cambridge University Press, New York NY2009
• American Society of Clinical Oncology 2009 Educational Book 
  Chapter: Allogeneic hematopoietic cell transplantation in older patients with myelodysplastic syndrome 
  Page 420 - 424Deeg,H.J.American Society of Clinical Oncology, Alexandria, VA2009
• Hematopoietic Stem Cell Transplantation 
  Chapter: Acute graft-versus-host disease 
  Page 589 - 620Benesch,M., Deeg,H.J.Editors: Soiffer,R.J..Humana Press, Totowa, NJEdition Seco,2008
• Hematopoietic Stem Cell Transplantation 
  Chapter: Allogeneic hematopoietic cell transplantation for patients with myelodysplastic syndrome and myeloproliferative disorders 
  Page 167 - 182Ramakrishnan,A., Deeg,H.J.Editors: Soiffer,R.J..Humana Press, Totowa, NJEdition Seco,2008
• Cancer Survivorship: Today and Tomorrow 
  Chapter: Medical and psychosocial issues in transplant survivors 
  Page 188 - 214Syrjala,K.L., Martin,P., Deeg,J., Boeckh, M.Editors: Ganz,P.A..Springer Science+Business Media, LLC, New York NY2007
• Oncology: An Evidence-Based Approach 
  Chapter: Medical and psychosocial issues in transplant survivors 
  Page 1902 - 1928Syrjala,K.L., Martin,P., Deeg,J., Boeckh, MEditors: Chang,A.E., Ganz,P.A., Hayes,D.F., Kinsella,T.J., Pass,H.I., Schiller,J.H., Stone,R.M., and Strecher,V.J..Springer Science + Business Media, Inc., New York, NY2006
• Myelodysplastic Syndromes: Clinical and Biological Advances 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndromes 
  Page 243 - 262Deeg,H.J., Scott,B.Editors: Greenberg, P.L..Cambridge University Press, Cambridge, UK2006
• Hematologic Malignancies: Myelodysplastic Syndromes 
  Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., Niemeyer,C..Springer, Heidelberg, Germany2006
• Hematologic Malignancies: Myelodysplastic Syndromes 
  Chapter: Second malignancies 
  Page 135 - 136Deeg,H.J.Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C.Springer, Heidelberg, Germany2006
• Join now to see all

Abstracts/Posters

• Determining eligibility for autologous hematopoietic cell transplantation
  Holmberg,L.A., Deeg,H.J., Sandmaier,B.M., 1/1/2011

Other

• Hematopoietic cell transplantation for myelofibrosis 
  Gerds,A.T., Scott,B.L., Deeg,H.J., Myeloproliferative Neoplasms: A Clinicians Guide App (eBook),
  1/15/2014
• Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience 
  Yusuf, U., Frangoul, H.A., Gooley, T.A., Woolfrey, A.E., Carpenter, P.A., Andrews, R.G., Deeg, H.J., Appelbaum, F.R., Anasetti, C., Storb, R., Sanders, J.E, Bone Marrow Transplant. Advance online
  1/2/2004
• Hematopoietic cell transplantation for myelodysplastic syndromes (MDS). 
  Scott,B., Deeg,H.J., The MDS News
  1/1/2004
• Myelodysplastic Syndromes 
  Greenberg, P.L., Baer, M., Bennett, J.M., Bloomfield, C.D., DeCastro, C.M., Deeg, H.J., Devetten, M., Emanuel, P.D., Erba, H.P., Estey, E., Foran, J., Gore, S.D., Mill..., National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology v.1. 2005
  http://www.nccn.org/professionals/physician_gls/PDF/mds.pdf
  1/1/2004
• Ueber das Rectum-Carcinom unter besonderer Beruecksichtigung des TNM-Systems, Inaugural Dissertation 
  Deeg, H.J., University of Bonn, School of Medicine
  1/1/1972
• Determining eligibility for allogeneic hematopoietic cell transplantation 
  Deeg HJ, Sandmaier BM
  http://www.uptodate.com/contents/determining-eligibility-for-allogeneic-hematopoietic-cell-transplan
  UpToDate, Wolters Kluwer Health - 2013-03-29
• Determining eligibility for autologous hematopoietic cell transplantation 
  Deeg HJ, Sandmaier BM, Holmberg LA
  http://www.uptodate.com/contents/determining-eligibility-for-autologous-hematopoietic-cell-transplan
  UpToDate, Wolters Kluwer Health - 2012-03-06
• Join now to see all